TRM-1
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TRM-1, covering 2013-08-02 to 2013-08-02. Get the full timeline:
Most recent: Clinical Trial Update: Study of TRM-1(TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC) [Phase 2]